DHPA joined with 215 advocacy groups to voice concern about Medicare Part B proposals outlined in President Trump’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs and corresponding Request for Information (RFI) that could have harmful consequences for patients with serious diseases. In a letter to HHS Secretary Alex Azar, the groups wrote, “As […]
Letters to Policymakers
DHPA Submits Comments in Response to Medicare Red Tape Relief Project on Physician-Focused Payment Models
DHPA has submitted comments that propose ways to streamline the development and approval of Physician-Focused Payment Models (PFPMs) to the U.S. House Ways and Means Health Subcommittee’s Medicare Red Tape Relief Project. The new initiative is aimed at “delivering relief from the regulations and mandates that impede innovation, drive up costs, and ultimately stand in […]
DHPA Submits Stark Law Modernization Comments in Response to Medicare Red Tape Relief Project
DHPA has submitted comments on the importance of modernizing the federal physician self-referral law (Stark Law) to the U.S. House Ways and Means Health Subcommittee’s Medicare Red Tape Relief Project, an initiative aimed at “delivering relief from the regulations and mandates that impede innovation, drive up costs, and ultimately stand in the way of delivering […]
DHPA Comments on CY 2018 Updates to Quality Payment Program
DHPA has filed comments in response to CMS’s CY 2018 Updates to the Quality Payment Program (“QPP”) Proposed Rule. In its comment letter, DHPA provided three specific suggestions for CMS to consider incorporating into the Final Rule to ensure Medicare beneficiaries’ continued access to critically important drug treatments and to facilitate greater participation by independent […]
DHPA Joins in Effort to Protect Patient Access to Physician-Administered Drugs
DHPA joined 268 other leading physician organizations in sending a letter to the Secretary of the U.S. Department of Health and Human Services, Dr. Thomas E. Price, regarding recent policy recommendations that, if implemented, could jeopardize seniors’ access to physician-administered drugs under Medicare Part B, force community clinics to close, and increase costs for seniors. […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 7
- Next Page »